Ibi -

For individuals with complex, chronic conditions like RA, finding the right treatment can be a long and difficult journey. Many are facing high costs due to cost sharing for premiums, deductibles, and Rx out-of-pocket (OOP) amounts. Manufacturers offer commercial co-pay assistance, but there are financial limits to this help. Programs are being offered to reverse application of this assistance from a member’s deductible, but that process can result in a financial burden to members. It has been shown that when some members face higher cost sharing for their medications, they become non-adherent to their therapy. For some patients, medication non-adherence has been associated with increased utilization of costly health care services such as emergency room (ER) visits and hospitalizations. Other strategies exist that can help members stay on treatment as prescribed.


Related Posts
    Current or Archive

    see all topics

    see all topics
    Keyword Search
      2022 Health and Productivity Forum Highlights Challenges of Remote Work, High-Cost Therapies, and More
      Nov 1, 2022
      Breast Cancer Costs Everyone
      Oct 12, 2022
      September is Pain Awareness Month: Creating a Supportive and Safe Work Environment
      Sep 22, 2022

      IBI Membership


      Get access to the latest tools and research on health and productivity.

      IBI Tools


      Use our resources and proprietary tools to turn data into action.